Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Infect Dis (Lond) ; 54(11): 810-818, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35854671

RESUMEN

BACKGROUND: COVID-19 may trigger an acute hyperinflammatory syndrome characterised by heightened levels of acute phase reactants and is associated with adverse outcomes among hospitalised individuals. The relationship between 48-hour changes in acute phase reactants and adverse outcomes is unclear. This study evaluated the relationship between change in four acute phase reactants (interleukin-6, procalcitonin, ferritin, and C-reactive protein), and the risk for in-hospital death and invasive mechanical ventilation. METHODS: A retrospective cohort among 2,523 adult patients hospitalised with COVID-19 pneumonia was conducted. Changes in IL-6, procalcitonin, ferritin, and CRP from admission to 48 h after admission were recorded. Delta was calculated using the difference in each acute phase reactant at admission and at 48-hours. Delta in acute phase reactants and the risk for in-hospital death and invasive mechanical ventilation was assessed using logistic regression models adjusting for demographics and comorbidities. RESULTS: Patients with both admission and 48-hour measurement for interleukin-6 (IL-6) (n = 541), procalcitonin (n = 828), ferritin (n = 1022), and C-reactive protein (CRP) (n = 1919) were included. Baseline characteristics were similar across all four populations. Increases in ferritin associated with a heightened risk of in-hospital death (OR 1.00032; 95%CI 1.00007- 1.00056; p < .001) and invasive mechanical ventilation (OR 1.00035; 95%CI 1.00014- 1.00055; p = .001). Therefore, for every 100 ng/mL increase in ferritin, the odds for in-hospital death and invasive mechanical ventilation increase by 3.2% and 3.5%, respectively. CONCLUSIONS: Delta in ferritin is associated with in-hospital death and invasive mechanical ventilation. Other acute phase reactants were not associated with these outcomes among COVID-19 inpatients.


Asunto(s)
COVID-19 , Adulto , Proteína C-Reactiva , COVID-19/terapia , Ferritinas , Mortalidad Hospitalaria , Humanos , Interleucina-6 , Polipéptido alfa Relacionado con Calcitonina , Respiración Artificial , Estudios Retrospectivos , SARS-CoV-2
2.
Am J Infect Control ; 48(10): 1270-1272, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32122672

RESUMEN

Health care workers (HCWs) are constantly exposed to patients with Clostridiodes difficile infection (CDI) although their risk developing infection is unknown. We designed a retrospective comparative study including HCWs with CDI and 2 comparator groups with a 1:2 ratio: HCWs without CDI and admitted patients with CDI. Antibiotics were the strongest risk factor for developing CDI in HCWs whether or not there was clinical exposure to patients with this infection.


Asunto(s)
Clostridioides difficile , Infecciones por Clostridium , Clostridioides , Infecciones por Clostridium/epidemiología , Personal de Salud , Humanos , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA